CN112294732A - Moisturizing composition and preparation method thereof - Google Patents

Moisturizing composition and preparation method thereof Download PDF

Info

Publication number
CN112294732A
CN112294732A CN202010616070.5A CN202010616070A CN112294732A CN 112294732 A CN112294732 A CN 112294732A CN 202010616070 A CN202010616070 A CN 202010616070A CN 112294732 A CN112294732 A CN 112294732A
Authority
CN
China
Prior art keywords
parts
polydimethylsiloxane
phase
extract
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010616070.5A
Other languages
Chinese (zh)
Inventor
张莹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xi'an Bohe Medical Technology Co ltd
Original Assignee
Xi'an Bohe Medical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xi'an Bohe Medical Technology Co ltd filed Critical Xi'an Bohe Medical Technology Co ltd
Priority to CN202010616070.5A priority Critical patent/CN112294732A/en
Publication of CN112294732A publication Critical patent/CN112294732A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585Organosilicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8111Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

The invention provides a moisturizing composition, which comprises a phase A, a phase B and a phase C, wherein the phase C comprises: bisabolol, ginger root extract, rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract, rice bran extract, caprylic/capric triglyceride, spilanthol extract, phenoxyethanol, and ethylhexylglycerin. The moisturizing composition disclosed by the invention can achieve a long-term moisturizing effect, has good use feeling and is stable in property.

Description

Moisturizing composition and preparation method thereof
Technical Field
The invention relates to the field of skin care products, and particularly relates to a moisturizing composition and a preparation method thereof.
Background
With the pace of modern life increasing, more and more young people work and rest irregularly, and the skin becomes sensitive and fragile. Dry skin and lack of water become one of the external causes of sensitive and fragile skin, and therefore, a large number of moisturizing products are available on the market.
The skin is the largest organ of the human body, not only plays a role in protecting the skin, but also plays a role in keeping one's health and beauty, particularly the facial skin, not only influences the appearance of the skin when the skin is lack of water and dry, but also causes uncomfortable feelings to consumers subjectively and possibly causes deterioration of certain skin diseases, and leads to premature aging of the skin. The hydration state and the loss degree of the skin are directly related to the softness and elasticity of the skin, and the moisture degree of the skin can be maintained to enhance the elasticity of the skin, ensure the normal metabolism of the skin and reduce the generation of wrinkles and color spots. The moisturizing effect is the most basic function of the skin care cosmetic, and how to improve the moisturizing effect of the skin care cosmetic has important significance on research and development and medical clinical application of the skin care cosmetic.
Most of the existing moisturizing products are pure water formulations, the formulation has the defects that long-term moisturizing effect is lacked, a large amount of alcohol is used as a solvent to dissolve raw materials with poor water solubility, the moisturizing effect of the product is achieved, but the moisturizing agent is not suitable for sensitive skin, the moisturizing effect cannot be better achieved, the skin is more sensitive after long-term use, and the absorption effect is poor.
Therefore, in the field of skin care products, there is a need for a moisturizing composition that is excellent in skin feel and has a long-term moisturizing effect.
Disclosure of Invention
In view of the above, an object of the present invention is to provide a moisturizing composition having excellent skin feel and a long-term moisturizing effect.
Therefore, the invention provides the following technical scheme.
In a first aspect, the present invention provides a moisturizing composition comprising a phase a, a phase B, and a phase C, wherein,
the phase A comprises: glycerin, disodium ethylene diamine tetraacetate, sodium hyaluronate, propylene glycol, dipotassium glycyrrhizinate, xanthan gum and water;
the phase B comprises: isononyl isononanoate, cetyl PEG/PPG-10/1 polydimethylsiloxane, PEG-9 Dimethylsiloxyethyl polydimethylsiloxane, hydrogenated polyisobutene, silica, synthetic wax, Cyclopentadimethylsiloxane, polydimethylsiloxane PEG-10/15 crosspolymer, polydimethylsiloxane, isododecane and disteardimonium hectorite;
the phase C comprises: bisabolol, ginger root extract, rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract, rice bran extract, caprylic/capric triglyceride, spilanthol extract, phenoxyethanol, and ethylhexylglycerin.
In a preferred embodiment of the present invention,
the total weight of the bisabolol and the ginger root extract is 0.1-2 parts; for example, the sum of the parts by weight of bisabolol and the ginger root extract is 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9 or 2 parts.
The total weight of the rapeseed oil, the glycyrrhiza glabra root extract, the polyglycerol-3 diisostearate, the marshmallow root extract and the rice chaff extract is 0.1-5 parts; for example, the sum of the parts by weight of rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract and rice chaff extract is 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, 2.2, 2.5, 2.7, 2.9, 3, 3.2, 3.5, 3.7, 3.8, 4, 4.1, 4.3, 4.5, 4.7, 4.9 or 5 parts.
The sum of the parts by weight of the caprylic/capric triglyceride and the spilanthol flower extract is 0.1-2 parts; for example, the sum of the parts by weight of caprylic/capric triglyceride and the spilanthol extract is 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9 or 2 parts.
The sum of the parts by weight of the phenoxyethanol and the ethylhexyl glycerol is 0.1 to 2 parts; for example, the sum of the parts by weight of phenoxyethanol and ethylhexyl glycerol is 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, or 2 parts.
In a preferred embodiment, the phase B comprises, in parts by weight: 2-6 parts of isononyl isononanoate, 0.1-2 parts of cetyl PEG/PPG-10/1 polydimethylsiloxane, 0.1-2 parts of PEG-9 polydimethylsiloxane, 0.1-3 parts of hydrogenated polyisobutene, 0.1-6 parts of silica, 0.1-6 parts of synthetic wax, 0.1-6 parts of cyclopentadimethylsiloxane, 0.1-6 parts of polydimethylsiloxane PEG-10/15 cross-linked polymer, 0.1-6 parts of polydimethylsiloxane, 0.1-4 parts of isododecane and 0.1-2 parts of disteardimonium hectorite.
In a preferred embodiment, the phase B comprises, in parts by weight: 2-5 parts of isononyl isononanoate, 0.1-1 part of cetyl PEG/PPG-10/1 polydimethylsiloxane, 0.1-1 part of PEG-9 polydimethylsiloxane, 0.1-2 parts of hydrogenated polyisobutene, 0.1-4 parts of silica, 0.1-4 parts of synthetic wax, 0.1-4 parts of cyclopentadimethylsiloxane, 0.1-4 parts of polydimethylsiloxane PEG-10/15 cross-linked polymer, 0.1-4 parts of polydimethylsiloxane, 0.1-3 parts of isododecane and 0.1-1 part of disteardimonium hectorite.
In a preferred embodiment, the phase B comprises, in parts by weight: 3-6 parts of isononyl isononanoate, 1-2 parts of cetyl PEG/PPG-10/1 polydimethylsiloxane, 0.5-2 parts of PEG-9 polydimethylsiloxane ethyl polydimethylsiloxane, 1-3 parts of hydrogenated polyisobutene, 3-6 parts of silica, 3-6 parts of synthetic wax, 3-6 parts of cyclopentadimethylsiloxane, 3-6 parts of polydimethylsiloxane PEG-10/15 cross-linked polymer, 3-6 parts of polydimethylsiloxane oil, 2-4 parts of isododecane and 1-2 parts of disteardimonium hectorite.
In a preferred embodiment, the phase a comprises, in parts by weight: 4-10 parts of glycerin, 0.1-0.3 part of disodium ethylene diamine tetraacetate, 0.1-0.2 part of sodium hyaluronate, 1-6 parts of propylene glycol, 0.1-1 part of dipotassium glycyrrhizinate, 0.1-0.3 part of xanthan gum and water.
In a preferred embodiment, the phase a comprises, in parts by weight: 4-6 parts of glycerin, 0.1-0.2 part of disodium ethylene diamine tetraacetate, 0.1-0.2 part of sodium hyaluronate, 1-3 parts of propylene glycol, 0.1-0.5 part of dipotassium glycyrrhizinate, 0.1-0.2 part of xanthan gum and water.
In a preferred embodiment, the phase a comprises, in parts by weight: 7-10 parts of glycerol, 0.2-0.3 part of disodium ethylene diamine tetraacetate, 0.1-0.2 part of sodium hyaluronate, 4-6 parts of propylene glycol, 0.5-1 part of dipotassium glycyrrhizinate, 0.2-0.3 part of xanthan gum and water.
In a more preferred embodiment of the present invention,
the total weight of the bisabolol and the ginger root extract is 0.5 part;
the total weight of the rapeseed oil, the glycyrrhiza glabra root extract, the polyglycerol-3 diisostearate, the marshmallow root extract and the rice chaff extract is 1 part;
the sum of the parts by weight of the caprylic/capric triglyceride and the spilanthol flower extract is 1 part;
the sum of the parts by weight of the phenoxyethanol and the ethylhexyl glycerol is 0.5 part.
In a more preferred embodiment, the phase B comprises, in parts by weight: 4 parts of isononyl isononanoate, 1 part of cetyl PEG/PPG-10/1 polydimethylsiloxane, 1.5 parts of PEG-9 polydimethylsiloxyethyl polydimethylsiloxane, 3 parts of hydrogenated polyisobutene, 5 parts of silica, 6 parts of synthetic wax, 6 parts of cyclopentadimethylsiloxane, 5 parts of polydimethylsiloxane PEG-10/15 crosspolymer, 2 parts of polydimethylsiloxane oil, 3 parts of isododecane and 1.2 parts of disteardimonium hectorite.
In a more preferred embodiment, the phase a comprises, in parts by weight: 8 parts of glycerin, 0.2 part of disodium ethylene diamine tetraacetate, 0.1 part of sodium hyaluronate, 5 parts of propylene glycol, 0.5 part of dipotassium glycyrrhizinate, 0.1 part of xanthan gum and water.
In a second aspect, the present invention provides a moisturizing composition consisting of phases a, B, and C, wherein,
the phase A consists of the following substances: glycerin, disodium ethylene diamine tetraacetate, sodium hyaluronate, propylene glycol, dipotassium glycyrrhizinate, xanthan gum and water;
the phase B consists of the following substances: isononyl isononanoate, cetyl PEG/PPG-10/1 polydimethylsiloxane, PEG-9 Dimethylsiloxyethyl polydimethylsiloxane, hydrogenated polyisobutene, silica, synthetic wax, Cyclopentadimethylsiloxane, polydimethylsiloxane PEG-10/15 crosspolymer, polydimethylsiloxane, isododecane and disteardimonium hectorite;
the phase C consists of the following substances: bisabolol, ginger root extract, rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract, rice bran extract, caprylic/capric triglyceride, spilanthol extract, phenoxyethanol, and ethylhexylglycerin.
In a preferred embodiment of the present invention,
the total weight of the bisabolol and the ginger root extract is 0.1-2 parts; (ii) a For example, the sum of the parts by weight of bisabolol and the ginger root extract is 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9 or 2 parts.
The total weight of the rapeseed oil, the glycyrrhiza glabra root extract, the polyglycerol-3 diisostearate, the marshmallow root extract and the rice chaff extract is 0.1-5 parts; for example, the sum of the parts by weight of rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract and rice chaff extract is 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, 2.2, 2.5, 2.7, 2.9, 3, 3.2, 3.5, 3.7, 3.8, 4, 4.1, 4.3, 4.5, 4.7, 4.9 or 5 parts.
The sum of the parts by weight of the caprylic/capric triglyceride and the spilanthol flower extract is 0.1-2 parts; for example, the sum of the parts by weight of caprylic/capric triglyceride and the spilanthol extract is 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9 or 2 parts.
The sum of the parts by weight of the phenoxyethanol and the ethylhexyl glycerol is 0.1 to 2 parts; for example, the sum of the parts by weight of phenoxyethanol and ethylhexyl glycerol is 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, or 2 parts.
In a preferred embodiment, the phase B consists of the following parts by weight:
2-6 parts of isononyl isononanoate, 0.1-2 parts of cetyl PEG/PPG-10/1 polydimethylsiloxane, 0.1-2 parts of PEG-9 polydimethylsiloxane, 0.1-3 parts of hydrogenated polyisobutene, 0.1-6 parts of silica, 0.1-6 parts of synthetic wax, 0.1-6 parts of cyclopentadimethylsiloxane, 0.1-6 parts of polydimethylsiloxane PEG-10/15 cross-linked polymer, 0.1-6 parts of polydimethylsiloxane, 0.1-4 parts of isododecane and 0.1-2 parts of disteardimonium hectorite.
In a preferred embodiment, the phase B consists of the following parts by weight:
2-5 parts of isononyl isononanoate, 0.1-1 part of cetyl PEG/PPG-10/1 polydimethylsiloxane, 0.1-1 part of PEG-9 polydimethylsiloxane, 0.1-2 parts of hydrogenated polyisobutene, 0.1-4 parts of silica, 0.1-4 parts of synthetic wax, 0.1-4 parts of cyclopentadimethylsiloxane, 0.1-4 parts of polydimethylsiloxane PEG-10/15 cross-linked polymer, 0.1-4 parts of polydimethylsiloxane, 0.1-3 parts of isododecane and 0.1-1 part of disteardimonium hectorite.
In a preferred embodiment, the phase B consists of the following parts by weight:
3-6 parts of isononyl isononanoate, 1-2 parts of cetyl PEG/PPG-10/1 polydimethylsiloxane, 0.5-2 parts of PEG-9 polydimethylsiloxane ethyl polydimethylsiloxane, 1-3 parts of hydrogenated polyisobutene, 3-6 parts of silica, 3-6 parts of synthetic wax, 3-6 parts of cyclopentadimethylsiloxane, 3-6 parts of polydimethylsiloxane PEG-10/15 cross-linked polymer, 3-6 parts of polydimethylsiloxane oil, 2-4 parts of isododecane and 1-2 parts of disteardimonium hectorite.
In a preferred embodiment, the phase a consists of the following parts by weight:
4-10 parts of glycerin, 0.1-0.3 part of disodium ethylene diamine tetraacetate, 0.1-0.2 part of sodium hyaluronate, 1-6 parts of propylene glycol, 0.1-1 part of dipotassium glycyrrhizinate, 0.1-0.3 part of xanthan gum and water.
In a preferred embodiment, the phase a consists of the following parts by weight:
4-6 parts of glycerin, 0.1-0.2 part of disodium ethylene diamine tetraacetate, 0.1-0.2 part of sodium hyaluronate, 1-3 parts of propylene glycol, 0.1-0.5 part of dipotassium glycyrrhizinate, 0.1-0.2 part of xanthan gum and water.
In a preferred embodiment, the phase a consists of the following parts by weight:
7-10 parts of glycerol, 0.2-0.3 part of disodium ethylene diamine tetraacetate, 0.1-0.2 part of sodium hyaluronate, 4-6 parts of propylene glycol, 0.5-1 part of dipotassium glycyrrhizinate, 0.2-0.3 part of xanthan gum and water.
In a more preferred embodiment of the present invention,
the total weight of the bisabolol and the ginger root extract is 0.5 part;
the total weight of the rapeseed oil, the glycyrrhiza glabra root extract, the polyglycerol-3 diisostearate, the marshmallow root extract and the rice chaff extract is 1 part;
the sum of the parts by weight of the caprylic/capric triglyceride and the spilanthol flower extract is 1 part;
the sum of the parts by weight of the phenoxyethanol and the ethylhexyl glycerol is 0.5 part.
In a more preferred embodiment, the phase B consists of the following parts by weight:
4 parts of isononyl isononanoate, 1 part of cetyl PEG/PPG-10/1 polydimethylsiloxane, 1.5 parts of PEG-9 polydimethylsiloxyethyl polydimethylsiloxane, 3 parts of hydrogenated polyisobutene, 5 parts of silica, 6 parts of synthetic wax, 6 parts of cyclopentadimethylsiloxane, 5 parts of polydimethylsiloxane PEG-10/15 crosspolymer, 2 parts of polydimethylsiloxane oil, 3 parts of isododecane and 1.2 parts of disteardimonium hectorite.
In a more preferred embodiment, the phase a consists of the following parts by weight:
8 parts of glycerin, 0.2 part of disodium ethylene diamine tetraacetate, 0.1 part of sodium hyaluronate, 5 parts of propylene glycol, 0.5 part of dipotassium glycyrrhizinate, 0.1 part of xanthan gum and water.
In a third aspect, there is provided a method of preparing a moisturizing composition of the present invention, wherein the method comprises the steps of:
s1, sequentially adding water, glycerol, propylene glycol, sodium hyaluronate, xanthan gum, disodium ethylene diamine tetraacetate and dipotassium glycyrrhizinate into a container, mixing, heating to 80-85 ℃, uniformly stirring, and keeping the temperature for 15min to obtain a phase A;
s2, heating isononyl isononanoate, cetyl PEG/PPG-10/1 polydimethylsiloxane, PEG-9 polydimethylsiloxane ethyl polydimethylsiloxane, hydrogenated polyisobutene, silica, synthetic wax, cyclopentadimethylsiloxane, polydimethylsiloxane PEG-10/15 cross-linked polymer, polydimethylsiloxane, isododecane and disteardimonium hectorite to 75-80 ℃, mixing and stirring for 10min, homogenizing for 2-3min, and stirring for 10min to obtain a phase B;
s3, slowly adding the phase A into the phase B at the temperature of 80 ℃, stirring for 30min, homogenizing for 3min, cooling to 55-60 ℃, then not stirring, standing and cooling until the temperature is reduced to 40 ℃;
s4, mixing and stirring bisabolol, a ginger root extract, rapeseed oil, a glabrous greenbrier rhizome extract, polyglycerol-3 diisostearate, a marshmallow root extract, a rice chaff extract, caprylic/capric triglyceride, a spilanthol flower extract, phenoxyethanol and ethylhexyl glycerin uniformly to obtain a phase C;
s5, mixing the phase C with the mixed phase obtained in the step S3, stirring for 20min, and cooling to room temperature.
In a fourth aspect, a skin care product is provided comprising the moisturizing composition of the present invention.
In a fifth aspect, a pharmaceutical composition is provided comprising a safe and effective amount of a moisturizing composition according to the present invention.
In a sixth aspect, there is provided the use of a moisturising composition according to the invention in the manufacture of a skin care product.
In a seventh aspect, there is provided the use of a moisturizing composition of the present invention in the preparation of a pharmaceutical composition.
In the present invention, the skin care product may include containers, instructions for use, use aids, and/or other structures and/or reagents as desired for performing the performance test; adjuvants used in the skin care products of the present invention include, but are not limited to, oils, emulsifiers, humectants, thickeners, skin conditioning agents, and/or preservatives; other structures required for performing performance tests in the skin care products of the present invention include, but are not limited to, structures for sampling, structures for performing control, and/or structures for observing the course or result of the assay; the other agents required for performing performance tests in the skin care products of the present invention include, but are not limited to, culture media, detergents, developers, and/or terminators.
In the invention, the pharmaceutical composition comprises the moisturizing composition and pharmaceutically acceptable auxiliary materials.
In the present invention, a safe and effective amount refers to an amount of a compound or composition sufficient to significantly induce a positive benefit, preferably a positive skin tissue appearance or feel benefit, including the benefits disclosed herein, either individually or in combination, but low enough to avoid serious side effects, i.e., to provide a reasonable benefit to risk ratio, within the scope of sound judgment of the skilled artisan.
Compared with the prior art, the invention has the beneficial effects that:
the moisturizing composition comprises a phase A, a phase B and a phase C, wherein a skin feel modifier such as silica and synthetic wax is added, and oil-soluble components such as rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, radix althae officinalis extract, rice chaff extract, caprylic/capric triglyceride, spilanthol extract, bisabolol, ginger root extract and dipotassium glycyrrhizinate are added, so that the moisturizing effect of sodium hyaluronate can be exerted to the maximum extent through mutual cooperation.
The preparation method of the moisturizing composition comprises the steps of slowly adding the water phase into the oil phase, uniformly stirring, homogenizing, cooling to 55-60 ℃, then not stirring, standing, cooling, adding oil-soluble components such as bisabolol, ginger root extract, rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, hollyhock root extract, rice chaff extract, caprylic/capric triglyceride, spilanthol extract, phenoxyethanol and ethylhexyl glycerin until the temperature is reduced to 40 ℃, and uniformly stirring to obtain the moisturizing composition which can exert a long-term moisturizing effect and is excellent and stable in skin feel.
Detailed Description
The present invention will be described in detail below with reference to specific embodiments and examples, and the advantages and various effects of the present invention will be more clearly apparent therefrom. It will be understood by those skilled in the art that these specific embodiments and examples are for the purpose of illustrating the invention and are not to be construed as limiting the invention.
Example 1
This example provides a moisturizing composition comprising phase a, phase B, phase C,
the phase A comprises: glycerin, disodium ethylene diamine tetraacetate, sodium hyaluronate, propylene glycol, dipotassium glycyrrhizinate, xanthan gum and water;
the phase B comprises: isononyl isononanoate, cetyl PEG/PPG-10/1 polydimethylsiloxane, PEG-9 Dimethylsiloxyethyl polydimethylsiloxane, hydrogenated polyisobutene, silica, synthetic wax, Cyclopentadimethylsiloxane, polydimethylsiloxane PEG-10/15 crosspolymer, polydimethylsiloxane, isododecane and disteardimonium hectorite;
the phase C comprises: bisabolol, ginger root extract, rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract, rice bran extract, caprylic/capric triglyceride, spilanthol extract, phenoxyethanol, and ethylhexylglycerin.
Wherein the content of the first and second substances,
the total weight of the bisabolol and the ginger root extract is 0.1 part;
the total weight of the rapeseed oil, the glycyrrhiza glabra root extract, the polyglycerol-3 diisostearate, the marshmallow root extract and the rice chaff extract is 0.1 part;
the sum of the parts by weight of the caprylic/capric triglyceride and the spilanthol flower extract is 0.1 part;
the sum of the parts by weight of the phenoxyethanol and the ethylhexyl glycerol is 0.1 part.
Wherein, the phase B comprises the following components in parts by weight: 2 parts isononyl isononanoate, 0.1 part cetyl PEG/PPG-10/1 polydimethylsiloxane, 0.1 part PEG-9 polydimethylsiloxyethyl polydimethylsiloxane, 0.1 part hydrogenated polyisobutene, 0.1 part silica, 0.1 part synthetic wax, 0.1 part cyclopentadimethylsiloxane, 0.1 part polydimethylsiloxane PEG-10/15 crosspolymer, 0.1 part dimethicone, 0.1 part isododecane, and 0.1 part disteardimonium hectorite.
Wherein, the phase A comprises the following components in parts by weight: 4 parts of glycerin, 0.1 part of disodium ethylene diamine tetraacetate, 0.1 part of sodium hyaluronate, 1 part of propylene glycol, 0.1 part of dipotassium glycyrrhizinate, 0.1 part of xanthan gum and water.
Example 2
This example provides a moisturizing composition comprising phase a, phase B, phase C,
the phase A comprises: glycerin, disodium ethylene diamine tetraacetate, sodium hyaluronate, propylene glycol, dipotassium glycyrrhizinate, xanthan gum and water;
the phase B comprises: isononyl isononanoate, cetyl PEG/PPG-10/1 polydimethylsiloxane, PEG-9 Dimethylsiloxyethyl polydimethylsiloxane, hydrogenated polyisobutene, silica, synthetic wax, Cyclopentadimethylsiloxane, polydimethylsiloxane PEG-10/15 crosspolymer, polydimethylsiloxane, isododecane and disteardimonium hectorite;
the phase C comprises: bisabolol, ginger root extract, rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract, rice bran extract, caprylic/capric triglyceride, spilanthol extract, phenoxyethanol, and ethylhexylglycerin.
Wherein the content of the first and second substances,
the total weight of the bisabolol and the ginger root extract is 2 parts;
the total weight parts of the rapeseed oil, the glycyrrhiza glabra root extract, the polyglycerol-3 diisostearate, the marshmallow root extract and the rice chaff extract are 5 parts;
the sum of the parts by weight of the caprylic/capric triglyceride and the spilanthol flower extract is 2 parts;
the sum of the parts by weight of the phenoxyethanol and the ethylhexyl glycerol is 2 parts.
Wherein, the phase B comprises the following components in parts by weight: 6 parts of isononyl isononanoate, 2 parts of cetyl PEG/PPG-10/1 polydimethylsiloxane, 2 parts of PEG-9 polydimethylsiloxyethyl polydimethylsiloxane, 3 parts of hydrogenated polyisobutene, 6 parts of silica, 6 parts of synthetic wax, 6 parts of cyclopentadimethylsiloxane, 6 parts of polydimethylsiloxane PEG-10/15 crosspolymer, 6 parts of polydimethylsiloxane oil, 4 parts of isododecane and 2 parts of disteardimonium hectorite.
Wherein, the phase A comprises the following components in parts by weight: 10 parts of glycerol, 0.3 part of disodium ethylene diamine tetraacetate, 0.2 part of sodium hyaluronate, 6 parts of propylene glycol, 1 part of dipotassium glycyrrhizinate, 0.3 part of xanthan gum and water.
Example 3
This example provides a moisturizing composition comprising phase a, phase B, phase C,
the phase A comprises: glycerin, disodium ethylene diamine tetraacetate, sodium hyaluronate, propylene glycol, dipotassium glycyrrhizinate, xanthan gum and water;
the phase B comprises: isononyl isononanoate, cetyl PEG/PPG-10/1 polydimethylsiloxane, PEG-9 Dimethylsiloxyethyl polydimethylsiloxane, hydrogenated polyisobutene, silica, synthetic wax, Cyclopentadimethylsiloxane, polydimethylsiloxane PEG-10/15 crosspolymer, polydimethylsiloxane, isododecane and disteardimonium hectorite;
the phase C comprises: bisabolol, ginger root extract, rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract, rice bran extract, caprylic/capric triglyceride, spilanthol extract, phenoxyethanol, and ethylhexylglycerin.
Wherein the content of the first and second substances,
the total weight of the bisabolol and the ginger root extract is 0.5 part;
the total weight of the rapeseed oil, the glycyrrhiza glabra root extract, the polyglycerol-3 diisostearate, the marshmallow root extract and the rice chaff extract is 1 part;
the sum of the parts by weight of the caprylic/capric triglyceride and the spilanthol flower extract is 1 part;
the sum of the parts by weight of the phenoxyethanol and the ethylhexyl glycerol is 0.5 part.
Wherein, the phase B comprises the following components in parts by weight: 4 parts of isononyl isononanoate, 1 part of cetyl PEG/PPG-10/1 polydimethylsiloxane, 1.5 parts of PEG-9 polydimethylsiloxyethyl polydimethylsiloxane, 3 parts of hydrogenated polyisobutene, 5 parts of silica, 6 parts of synthetic wax, 6 parts of cyclopentadimethylsiloxane, 5 parts of polydimethylsiloxane PEG-10/15 crosspolymer, 2 parts of polydimethylsiloxane oil, 3 parts of isododecane and 1.2 parts of disteardimonium hectorite.
Wherein, the phase A comprises the following components in parts by weight: 8 parts of glycerin, 0.2 part of disodium ethylene diamine tetraacetate, 0.1 part of sodium hyaluronate, 5 parts of propylene glycol, 0.5 part of dipotassium glycyrrhizinate, 0.1 part of xanthan gum and water.
Example 4
This example provides a moisturizing composition consisting of phases a, B, and C, wherein,
the phase A consists of the following substances: glycerin, disodium ethylene diamine tetraacetate, sodium hyaluronate, propylene glycol, dipotassium glycyrrhizinate, xanthan gum and water;
the phase B consists of the following substances: isononyl isononanoate, cetyl PEG/PPG-10/1 polydimethylsiloxane, PEG-9 Dimethylsiloxyethyl polydimethylsiloxane, hydrogenated polyisobutene, silica, synthetic wax, Cyclopentadimethylsiloxane, polydimethylsiloxane PEG-10/15 crosspolymer, polydimethylsiloxane, isododecane and disteardimonium hectorite;
the phase C consists of the following substances: bisabolol, ginger root extract, rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract, rice bran extract, caprylic/capric triglyceride, spilanthol extract, phenoxyethanol, and ethylhexylglycerin.
Wherein the content of the first and second substances,
the total weight of the bisabolol and the ginger root extract is 0.1 part;
the total weight of the rapeseed oil, the glycyrrhiza glabra root extract, the polyglycerol-3 diisostearate, the marshmallow root extract and the rice chaff extract is 0.1 part;
the sum of the parts by weight of the caprylic/capric triglyceride and the spilanthol flower extract is 0.1 part;
the sum of the parts by weight of the phenoxyethanol and the ethylhexyl glycerol is 0.1 part;
wherein the phase B consists of the following substances in parts by weight:
2 parts isononyl isononanoate, 0.1 part cetyl PEG/PPG-10/1 polydimethylsiloxane, 0.1 part PEG-9 polydimethylsiloxyethyl polydimethylsiloxane, 0.1 part hydrogenated polyisobutene, 0.1 part silica, 0.1 part synthetic wax, 0.1 part cyclopentadimethylsiloxane, 0.1 part polydimethylsiloxane PEG-10/15 crosspolymer, 0.1 part dimethicone, 0.1 part isododecane, and 0.1 part disteardimonium hectorite.
Wherein the phase A consists of the following substances in parts by weight:
4 parts of glycerin, 0.1 part of disodium ethylene diamine tetraacetate, 0.1 part of sodium hyaluronate, 1 part of propylene glycol, 0.1 part of dipotassium glycyrrhizinate, 0.1 part of xanthan gum and water.
Example 5
This example provides a moisturizing composition consisting of phases a, B, and C, wherein,
the phase A consists of the following substances: glycerin, disodium ethylene diamine tetraacetate, sodium hyaluronate, propylene glycol, dipotassium glycyrrhizinate, xanthan gum and water;
the phase B consists of the following substances: isononyl isononanoate, cetyl PEG/PPG-10/1 polydimethylsiloxane, PEG-9 Dimethylsiloxyethyl polydimethylsiloxane, hydrogenated polyisobutene, silica, synthetic wax, Cyclopentadimethylsiloxane, polydimethylsiloxane PEG-10/15 crosspolymer, polydimethylsiloxane, isododecane and disteardimonium hectorite;
the phase C consists of the following substances: bisabolol, ginger root extract, rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract, rice bran extract, caprylic/capric triglyceride, spilanthol extract, phenoxyethanol, and ethylhexylglycerin.
Wherein the content of the first and second substances,
the total weight of the bisabolol and the ginger root extract is 2 parts;
the total weight parts of the rapeseed oil, the glycyrrhiza glabra root extract, the polyglycerol-3 diisostearate, the marshmallow root extract and the rice chaff extract are 5 parts;
the sum of the parts by weight of the caprylic/capric triglyceride and the spilanthol flower extract is 2 parts;
the sum of the parts by weight of the phenoxyethanol and the ethylhexyl glycerin is 2 parts;
wherein the phase B consists of the following substances in parts by weight:
6 parts of isononyl isononanoate, 2 parts of cetyl PEG/PPG-10/1 polydimethylsiloxane, 2 parts of PEG-9 polydimethylsiloxyethyl polydimethylsiloxane, 3 parts of hydrogenated polyisobutene, 6 parts of silica, 6 parts of synthetic wax, 6 parts of cyclopentadimethylsiloxane, 6 parts of polydimethylsiloxane PEG-10/15 crosspolymer, 6 parts of polydimethylsiloxane oil, 4 parts of isododecane and 2 parts of disteardimonium hectorite.
Wherein the phase A consists of the following substances in parts by weight:
10 parts of glycerol, 0.3 part of disodium ethylene diamine tetraacetate, 0.2 part of sodium hyaluronate, 6 parts of propylene glycol, 1 part of dipotassium glycyrrhizinate, 0.3 part of xanthan gum and water.
Example 6
This example provides a moisturizing composition consisting of phases a, B, and C, wherein,
the phase A consists of the following substances: glycerin, disodium ethylene diamine tetraacetate, sodium hyaluronate, propylene glycol, dipotassium glycyrrhizinate, xanthan gum and water;
the phase B consists of the following substances: isononyl isononanoate, cetyl PEG/PPG-10/1 polydimethylsiloxane, PEG-9 Dimethylsiloxyethyl polydimethylsiloxane, hydrogenated polyisobutene, silica, synthetic wax, Cyclopentadimethylsiloxane, polydimethylsiloxane PEG-10/15 crosspolymer, polydimethylsiloxane, isododecane and disteardimonium hectorite;
the phase C consists of the following substances: bisabolol, ginger root extract, rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract, rice bran extract, caprylic/capric triglyceride, spilanthol extract, phenoxyethanol, and ethylhexylglycerin.
Wherein the content of the first and second substances,
the total weight of the bisabolol and the ginger root extract is 0.5 part;
the total weight of the rapeseed oil, the glycyrrhiza glabra root extract, the polyglycerol-3 diisostearate, the marshmallow root extract and the rice chaff extract is 1 part;
the sum of the parts by weight of the caprylic/capric triglyceride and the spilanthol flower extract is 1 part;
the sum of the parts by weight of the phenoxyethanol and the ethylhexyl glycerol is 0.5 part.
Wherein the phase B consists of the following substances in parts by weight:
4 parts of isononyl isononanoate, 1 part of cetyl PEG/PPG-10/1 polydimethylsiloxane, 1.5 parts of PEG-9 polydimethylsiloxyethyl polydimethylsiloxane, 3 parts of hydrogenated polyisobutene, 5 parts of silica, 6 parts of synthetic wax, 6 parts of cyclopentadimethylsiloxane, 5 parts of polydimethylsiloxane PEG-10/15 crosspolymer, 2 parts of polydimethylsiloxane oil, 3 parts of isododecane and 1.2 parts of disteardimonium hectorite.
Wherein the phase A consists of the following substances in parts by weight:
8 parts of glycerin, 0.2 part of disodium ethylene diamine tetraacetate, 0.1 part of sodium hyaluronate, 5 parts of propylene glycol, 0.5 part of dipotassium glycyrrhizinate, 0.1 part of xanthan gum and water.
Example 7
This example provides a moisturizing composition comprising a phase a, a phase B, and a phase C, wherein,
the phase A comprises: glycerin, disodium ethylene diamine tetraacetate, sodium hyaluronate, propylene glycol, dipotassium glycyrrhizinate, xanthan gum and water;
the phase B comprises: isononyl isononanoate, cetyl PEG/PPG-10/1 polydimethylsiloxane, PEG-9 Dimethylsiloxyethyl polydimethylsiloxane, hydrogenated polyisobutene, silica, synthetic wax, Cyclopentadimethylsiloxane, polydimethylsiloxane PEG-10/15 crosspolymer, polydimethylsiloxane, isododecane and disteardimonium hectorite;
the phase C comprises: bisabolol, ginger root extract, rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract, rice bran extract, caprylic/capric triglyceride, spilanthol extract, phenoxyethanol, and ethylhexylglycerin.
Example 8
This example provides a moisturizing composition consisting of phases a, B, and C, wherein,
the phase A consists of the following substances: glycerin, disodium ethylene diamine tetraacetate, sodium hyaluronate, propylene glycol, dipotassium glycyrrhizinate, xanthan gum and water;
the phase B consists of the following substances: isononyl isononanoate, cetyl PEG/PPG-10/1 polydimethylsiloxane, PEG-9 Dimethylsiloxyethyl polydimethylsiloxane, hydrogenated polyisobutene, silica, synthetic wax, Cyclopentadimethylsiloxane, polydimethylsiloxane PEG-10/15 crosspolymer, polydimethylsiloxane, isododecane and disteardimonium hectorite;
the phase C consists of the following substances: bisabolol, ginger root extract, rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract, rice bran extract, caprylic/capric triglyceride, spilanthol extract, phenoxyethanol, and ethylhexylglycerin.
Example 9
This example provides a method of preparing the moisturizing composition of example 3, wherein the method comprises the steps of:
s1, sequentially adding water, 8 parts of glycerol, 5 parts of propylene glycol, 0.1 part of sodium hyaluronate, 0.1 part of xanthan gum, 0.2 part of disodium ethylene diamine tetraacetate and 0.5 part of dipotassium glycyrrhizinate into a container, mixing, heating to 80 ℃, uniformly stirring, and keeping the temperature for 15min to obtain a phase A;
s2, heating 4 parts of isononyl isononanoate, 1 part of cetyl PEG/PPG-10/1 polydimethylsiloxane, 1.5 parts of PEG-9 polydimethylsiloxane ethyl polydimethylsiloxane, 3 parts of hydrogenated polyisobutene, 5 parts of silica, 6 parts of synthetic wax, 6 parts of cyclopentadimethylsiloxane, 5 parts of polydimethylsiloxane PEG-10/15 cross-linked polymer, 2 parts of polydimethylsiloxane oil, 3 parts of isododecane and 1.2 parts of disteardimonium hectorite to 75 ℃, mixing and stirring for 10min, homogenizing for 2min, and stirring for 10min to obtain a phase B;
s3, slowly adding the phase A into the phase B at the temperature of 80 ℃, stirring for 30min, homogenizing for 3min, cooling to 55 ℃, then not stirring, standing and cooling until the temperature is reduced to 40 ℃;
s4, mixing and stirring 0.5 part by weight of bisabolol and 0.5 part by weight of ginger root extract, 1 part by weight of rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, hollyhock root extract and rice chaff extract, 1 part by weight of caprylic/capric triglyceride and spicebush flower extract and 0.5 part by weight of phenoxyethanol and ethylhexyl glycerol uniformly to obtain a phase C;
s5, mixing the phase C with the mixed phase obtained in the step S3, stirring for 20min, and cooling to room temperature.
Example 10
This example provides a method of preparing the moisturizing composition of example 6, wherein the method comprises the steps of:
s1, sequentially adding water, 8 parts of glycerol, 5 parts of propylene glycol, 0.1 part of sodium hyaluronate, 0.1 part of xanthan gum, 0.2 part of disodium ethylene diamine tetraacetate and 0.5 part of dipotassium glycyrrhizinate into a container, mixing, heating to 80 ℃, uniformly stirring, and keeping the temperature for 15min to obtain a phase A;
s2, heating 4 parts of isononyl isononanoate, 1 part of cetyl PEG/PPG-10/1 polydimethylsiloxane, 1.5 parts of PEG-9 polydimethylsiloxane ethyl polydimethylsiloxane, 3 parts of hydrogenated polyisobutene, 5 parts of silica, 6 parts of synthetic wax, 6 parts of cyclopentadimethylsiloxane, 5 parts of polydimethylsiloxane PEG-10/15 cross-linked polymer, 2 parts of polydimethylsiloxane oil, 3 parts of isododecane and 1.2 parts of disteardimonium hectorite to 75 ℃, mixing and stirring for 10min, homogenizing for 2min, and stirring for 10min to obtain a phase B;
s3, slowly adding the phase A into the phase B at the temperature of 80 ℃, stirring for 30min, homogenizing for 3min, cooling to 55 ℃, then not stirring, standing and cooling until the temperature is reduced to 40 ℃;
s4, mixing and stirring 0.5 part by weight of bisabolol and 0.5 part by weight of ginger root extract, 1 part by weight of rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, hollyhock root extract and rice chaff extract, 1 part by weight of caprylic/capric triglyceride and spicebush flower extract and 0.5 part by weight of phenoxyethanol and ethylhexyl glycerol uniformly to obtain a phase C;
s5, mixing the phase C with the mixed phase obtained in the step S3, stirring for 20min, and cooling to room temperature.
Comparative example 1
Comparative example 1 provides a moisturizing composition comprising phase a, phase B, phase C,
the phase A comprises: glycerin, disodium ethylene diamine tetraacetate, sodium hyaluronate, propylene glycol, dipotassium glycyrrhizinate, xanthan gum and water;
the phase B comprises: isononyl isononanoate, cetyl PEG/PPG-10/1 polydimethylsiloxane, PEG-9 Dimethylsiloxyethyl polydimethylsiloxane, hydrogenated polyisobutene, silica, synthetic wax, Cyclopentadimethylsiloxane, polydimethylsiloxane PEG-10/15 crosspolymer, polydimethylsiloxane, isododecane and disteardimonium hectorite;
the phase C comprises: bisabolol, ginger root extract, rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract, rice bran extract, caprylic/capric triglyceride, spilanthol extract, phenoxyethanol, and ethylhexylglycerin.
Wherein the content of the first and second substances,
the total weight of the bisabolol and the ginger root extract is 0.05 part;
the total weight of the rapeseed oil, the glycyrrhiza glabra root extract, the polyglycerol-3 diisostearate, the marshmallow root extract and the rice chaff extract is 0.05 part;
the sum of the parts by weight of the caprylic/capric triglyceride and the spilanthol flower extract is 0.05 part;
the sum of the parts by weight of the phenoxyethanol and the ethylhexyl glycerol is 0.05 part.
Wherein, the phase B comprises the following components in parts by weight: 1 part isononyl isononanoate, 0.05 part cetyl PEG/PPG-10/1 polydimethylsiloxane, 0.05 part PEG-9 polydimethylsiloxyethyl polydimethylsiloxane, 0.05 part hydrogenated polyisobutene, 0.05 part silica, 0.05 part synthetic wax, 0.05 part cyclopentadimethylsiloxane, 0.05 part polydimethylsiloxane PEG-10/15 crosspolymer, 0.05 part dimethicone, 0.05 part isododecane, and 0.05 part disteardimonium hectorite.
Wherein, the phase A comprises the following components in parts by weight: 3 parts of glycerin, 0.05 part of disodium ethylene diamine tetraacetate, 0.05 part of sodium hyaluronate, 0.5 part of propylene glycol, 0.05 part of dipotassium glycyrrhizinate, 0.05 part of xanthan gum and water.
Comparative example 2
Comparative example 2 provides a moisturizing composition comprising phase a, phase B, phase C,
the phase A comprises: glycerin, disodium ethylene diamine tetraacetate, sodium hyaluronate, propylene glycol, dipotassium glycyrrhizinate, xanthan gum and water;
the phase B comprises: isononyl isononanoate, cetyl PEG/PPG-10/1 polydimethylsiloxane, PEG-9 Dimethylsiloxyethyl polydimethylsiloxane, hydrogenated polyisobutene, silica, synthetic wax, Cyclopentadimethylsiloxane, polydimethylsiloxane PEG-10/15 crosspolymer, polydimethylsiloxane, isododecane and disteardimonium hectorite;
the phase C comprises: bisabolol, ginger root extract, rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract, rice bran extract, caprylic/capric triglyceride, spilanthol extract, phenoxyethanol, and ethylhexylglycerin.
Wherein the content of the first and second substances,
the total weight of the bisabolol and the ginger root extract is 3 parts;
the total weight parts of the rapeseed oil, the glycyrrhiza glabra root extract, the polyglycerol-3 diisostearate, the marshmallow root extract and the rice chaff extract are 6 parts;
the sum of the parts by weight of the caprylic/capric triglyceride and the spilanthol flower extract is 3 parts;
the sum of the parts by weight of the phenoxyethanol and the ethylhexyl glycerol is 3 parts.
Wherein, the phase B comprises the following components in parts by weight: 7 parts of isononyl isononanoate, 2.5 parts of cetyl PEG/PPG-10/1 polydimethylsiloxane, 2.5 parts of PEG-9 polydimethylsiloxane, 4 parts of hydrogenated polyisobutene, 7 parts of silica, 6.5 parts of synthetic wax, 6.5 parts of cyclopentadimethylsiloxane, 6.5 parts of polydimethylsiloxane PEG-10/15 crosspolymer, 7 parts of polydimethylsiloxane oil, 5 parts of isododecane and 3 parts of disteardimonium hectorite.
Wherein, the phase A comprises the following components in parts by weight: 11 parts of glycerol, 0.4 part of disodium ethylene diamine tetraacetate, 0.3 part of sodium hyaluronate, 7 parts of propylene glycol, 2 parts of dipotassium glycyrrhizinate, 0.4 part of xanthan gum and water.
Effect verification:
experiment 1: skin feel verification
And (3) testing a sample: samples prepared in inventive examples 1-6 and comparative examples 1-2
The experimental method comprises the following steps:
180 dry skin and allergy prone volunteers were selected, wherein the age distribution was 30-60 years, and were randomly divided into six groups of 30 individuals, and the samples prepared in examples 1-6 were used once a day, morning and evening, respectively, and were immediately used for questionnaires to investigate skin feel, moisture, viscosity, and overall satisfaction.
The test evaluation results are shown in table 1 below, and the evaluation score was 10 points.
Table 1 skin feel test evaluation results
Item Skin feel Degree of water wettability Overall satisfaction
Example 1 8 9 9
Example 2 9 8 9
Example 3 10 10 10
Example 4 8 9 9
Example 5 9 8 9
Example 6 10 10 10
Comparative example 1 5 5 5
Comparative example 2 6 5 6
From the above data, it can be seen that the moisturizing compositions prepared in examples 1-6 have high evaluation scores in terms of skin feel and water wettability, wherein the evaluation scores in terms of skin feel and water wettability are the highest in examples 3 and 6 of the present invention, and the overall satisfaction of examples 3 and 6 is the best to meet the requirements of consumers for skin care products. Whereas moisturizing compositions not using the present formulation system had lower evaluation scores in terms of skin feel, moisturization.
Experiment 2: moisture retention verification
And (3) testing a sample: samples prepared in inventive examples 1-6 and comparative examples 1-2
The experimental method comprises the following steps:
180 of the volunteers with allergy tendency and more skin problems were selected, wherein the age distribution was 30-50 years, and the samples prepared in examples 1-6 were randomly divided into six groups of 30 persons each, and the samples were used once every morning and evening, and after smearing, the mildness was evaluated, and after 28 days, the moisture content (the German CK test) and the thickness of the stratum corneum (the single wheat test) were tested. (average value for each set of tests)
Wherein, the test evaluation results are shown in the following table 2, and the evaluation score is 10 points
TABLE 2 evaluation results of moisture retention test
Figure 249203DEST_PATH_IMAGE001
From the above data, it can be seen that the moisture content of the face of the volunteers using the moisturizing compositions prepared in examples 1 to 6 was significantly increased, and the skin thickness was also significantly increased compared to before use, particularly the moisture content and skin thickness of examples 3 and 6 were significantly increased, indicating that the moisturizing composition of the present invention has a good long-term moisturizing effect, and is very good in improving the repair of the skin barrier, and the volunteers were smeared during allergy without irritation. The moisturizing composition without the formula system provided by the invention has poor long-term moisturizing effect, and has no obvious improvement on skin barrier repair of volunteers.
Experiment 3: stability verification
And (3) testing a sample: samples prepared according to examples 1-6, examples 9-10, and comparative examples 1-2 of the present invention
The experimental method comprises the following steps:
a proper amount of the samples prepared in the examples 1 to 6 and the comparative examples 1 to 2 were put in a 10mL centrifuge tube, and the samples were placed at 40 ℃ for 3 months, 45 ℃ for 1 month, 50 ℃ for 7 days and-20 ℃ for 1 month, and the presence or absence of hardening, demulsification, foaming, precipitation and the like was observed under various temperature conditions.
A proper amount of samples prepared in the examples 1-6 and the comparative examples 1-2 are placed in a 10mL centrifuge tube, centrifuged at 3000r/min for 30min, and the demulsification or precipitation phenomenon is observed.
Wherein, the test evaluation results are shown in the following table 3
Table 3 stability test results
Figure 431923DEST_PATH_IMAGE003
From the above data, it can be seen that the moisture content of the face of the volunteers using the moisturizing compositions prepared in examples 1 to 6 and 9 to 10 is significantly increased, and the skin thickness is also significantly increased compared to before use, particularly, the moisture content and the skin thickness of examples 3 and 6 are significantly increased, which indicates that the moisturizing composition of the present invention has a good long-term moisturizing effect, and is very good in repairing skin barrier, and the volunteers are smeared during allergy, and are not irritant. The moisturizing composition without the formula system provided by the invention has poor long-term moisturizing effect, and has no obvious improvement on skin barrier repair of volunteers.
After the moisturizing composition is tested under the five test conditions of 40 ℃, 45 ℃, 50 ℃, 20 ℃ and centrifugation, the shape of the moisturizing composition has no obvious change, and the test results are all qualified. The moisturizing composition without the formula system of the invention has poor cold resistance and heat resistance under long-term storage conditions, and cannot meet the use requirements under centrifugal conditions.
It is to be understood that the invention disclosed is not limited to the particular methodology, protocols, and materials described, as these may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the present invention which will be limited only by the appended claims.
Those skilled in the art will also recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the following claims.

Claims (10)

1. A moisturizing composition comprising a phase A, a phase B, and a phase C, wherein,
the phase A comprises: glycerin, disodium ethylene diamine tetraacetate, sodium hyaluronate, propylene glycol, dipotassium glycyrrhizinate, xanthan gum and water;
the phase B comprises: isononyl isononanoate, cetyl PEG/PPG-10/1 polydimethylsiloxane, PEG-9 Dimethylsiloxyethyl polydimethylsiloxane, hydrogenated polyisobutene, silica, synthetic wax, Cyclopentadimethylsiloxane, polydimethylsiloxane PEG-10/15 crosspolymer, polydimethylsiloxane, isododecane and disteardimonium hectorite;
the phase C comprises: bisabolol, ginger root extract, rapeseed oil, glycyrrhiza glabra root extract, polyglycerol-3 diisostearate, marshmallow root extract, rice bran extract, caprylic/capric triglyceride, spilanthol extract, phenoxyethanol, and ethylhexylglycerin.
2. The moisturizing composition of claim 1,
the total weight of the bisabolol and the ginger root extract is 0.1-2 parts;
the total weight of the rapeseed oil, the glycyrrhiza glabra root extract, the polyglycerol-3 diisostearate, the marshmallow root extract and the rice chaff extract is 0.1-5 parts;
the sum of the parts by weight of the caprylic/capric triglyceride and the spilanthol flower extract is 0.1-2 parts;
the sum of the parts by weight of the phenoxyethanol and the ethylhexyl glycerol is 0.1-2 parts.
3. The moisturizing composition of claim 1, wherein the phase B comprises, in parts by weight: 2-6 parts of isononyl isononanoate, 0.1-2 parts of cetyl PEG/PPG-10/1 polydimethylsiloxane, 0.1-2 parts of PEG-9 polydimethylsiloxane, 0.1-3 parts of hydrogenated polyisobutene, 0.1-6 parts of silica, 0.1-6 parts of synthetic wax, 0.1-6 parts of cyclopentadimethylsiloxane, 0.1-6 parts of polydimethylsiloxane PEG-10/15 cross-linked polymer, 0.1-6 parts of polydimethylsiloxane, 0.1-4 parts of isododecane and 0.1-2 parts of disteardimonium hectorite.
4. The moisturizing composition of claim 1, wherein the phase a comprises, in parts by weight: 4-10 parts of glycerin, 0.1-0.3 part of disodium ethylene diamine tetraacetate, 0.1-0.2 part of sodium hyaluronate, 1-6 parts of propylene glycol, 0.1-1 part of dipotassium glycyrrhizinate, 0.1-0.3 part of xanthan gum and water.
5. The moisturizing composition of claim 2,
the total weight of the bisabolol and the ginger root extract is 0.5 part;
the total weight of the rapeseed oil, the glycyrrhiza glabra root extract, the polyglycerol-3 diisostearate, the marshmallow root extract and the rice chaff extract is 1 part;
the sum of the parts by weight of the caprylic/capric triglyceride and the spilanthol flower extract is 1 part;
the sum of the parts by weight of the phenoxyethanol and the ethylhexyl glycerol is 0.5 part.
6. The moisturizing composition of claim 3, wherein the phase B comprises, in parts by weight: 4 parts of isononyl isononanoate, 1 part of cetyl PEG/PPG-10/1 polydimethylsiloxane, 1.5 parts of PEG-9 polydimethylsiloxyethyl polydimethylsiloxane, 3 parts of hydrogenated polyisobutene, 5 parts of silica, 6 parts of synthetic wax, 6 parts of cyclopentadimethylsiloxane, 5 parts of polydimethylsiloxane PEG-10/15 crosspolymer, 2 parts of polydimethylsiloxane oil, 3 parts of isododecane and 1.2 parts of disteardimonium hectorite.
7. The moisturizing composition of claim 4, wherein the phase A comprises, in parts by weight: 8 parts of glycerin, 0.2 part of disodium ethylene diamine tetraacetate, 0.1 part of sodium hyaluronate, 5 parts of propylene glycol, 0.5 part of dipotassium glycyrrhizinate, 0.1 part of xanthan gum and water.
8. A process for the preparation of a moisturizing composition as in any of claims 1-7, wherein the process comprises the steps of:
s1, sequentially adding water, glycerol, propylene glycol, sodium hyaluronate, xanthan gum, disodium ethylene diamine tetraacetate and dipotassium glycyrrhizinate into a container, mixing, heating to 80-85 ℃, uniformly stirring, and keeping the temperature for 15min to obtain a phase A;
s2, heating isononyl isononanoate, cetyl PEG/PPG-10/1 polydimethylsiloxane, PEG-9 polydimethylsiloxane ethyl polydimethylsiloxane, hydrogenated polyisobutene, silica, synthetic wax, cyclopentadimethylsiloxane, polydimethylsiloxane PEG-10/15 cross-linked polymer, polydimethylsiloxane, isododecane and disteardimonium hectorite to 75-80 ℃, mixing and stirring for 10min, homogenizing for 2-3min, and stirring for 10min to obtain a phase B;
s3, slowly adding the phase A into the phase B at the temperature of 80 ℃, stirring for 30min, homogenizing for 3min, cooling to 55-60 ℃, then not stirring, standing and cooling until the temperature is reduced to 40 ℃;
s4, mixing and stirring bisabolol, a ginger root extract, rapeseed oil, a glabrous greenbrier rhizome extract, polyglycerol-3 diisostearate, a marshmallow root extract, a rice chaff extract, caprylic/capric triglyceride, a spilanthol flower extract, phenoxyethanol and ethylhexyl glycerin uniformly to obtain a phase C;
s5, mixing the phase C with the mixed phase obtained in the step S3, stirring for 20min, and cooling to room temperature.
9. A skin care product comprising the moisturizing composition of any of claims 1-7.
10. Use of the moisturizing composition of any one of claims 1-7 in the preparation of a skin care product or a pharmaceutical composition.
CN202010616070.5A 2020-07-01 2020-07-01 Moisturizing composition and preparation method thereof Pending CN112294732A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010616070.5A CN112294732A (en) 2020-07-01 2020-07-01 Moisturizing composition and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010616070.5A CN112294732A (en) 2020-07-01 2020-07-01 Moisturizing composition and preparation method thereof

Publications (1)

Publication Number Publication Date
CN112294732A true CN112294732A (en) 2021-02-02

Family

ID=74483078

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010616070.5A Pending CN112294732A (en) 2020-07-01 2020-07-01 Moisturizing composition and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112294732A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230190627A1 (en) * 2021-12-16 2023-06-22 L'oreal No-rinse makeup removal composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104473786A (en) * 2014-12-26 2015-04-01 广东洁新生物科技有限公司 Skin cream and preparation method thereof
CN105769643A (en) * 2016-01-27 2016-07-20 广东芭薇生物科技股份有限公司 Water moisturizing cream and preparation method thereof
CN107737027A (en) * 2017-11-06 2018-02-27 诺斯贝尔化妆品股份有限公司 A kind of moisturizing sun screen of high stability

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104473786A (en) * 2014-12-26 2015-04-01 广东洁新生物科技有限公司 Skin cream and preparation method thereof
CN105769643A (en) * 2016-01-27 2016-07-20 广东芭薇生物科技股份有限公司 Water moisturizing cream and preparation method thereof
CN107737027A (en) * 2017-11-06 2018-02-27 诺斯贝尔化妆品股份有限公司 A kind of moisturizing sun screen of high stability

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230190627A1 (en) * 2021-12-16 2023-06-22 L'oreal No-rinse makeup removal composition

Similar Documents

Publication Publication Date Title
CN111249209B (en) Moisturizing repair cream and preparation method thereof
EP4144344A1 (en) Biomimetic and camellia extract-containing skin barrier repair composition and application thereof
CN112118856A (en) Topical skin care compositions comprising centella asiatica selected triterpenes
CN113398016A (en) Skin soothing and repairing composition and cosmetic composition
CN105168054A (en) Mask capable of supplementing water, whitening and removing wrinkles and preparation method of mask
CN109674687B (en) Emulsified lipstick and preparation method thereof
US7588775B2 (en) Silicone elastomer exfoliating compositions
CN113057902A (en) Camellia seed oil cream containing hydrolyzed vegetable protein and preparation method thereof
CN112716814A (en) Double-layer shaking essence and preparation method thereof
WO2023065651A1 (en) Lip balm composed of natural plant components and preparation method therefor
CN112237556A (en) Oil composition for repairing skin barrier and application thereof
CN108771643B (en) Nourishing and moistening repair essence
HU230039B1 (en) Hypoallergenic and non-irritant skin care formulations
CN112294732A (en) Moisturizing composition and preparation method thereof
US20110002883A1 (en) Therapeutic preparations containing wharton's jelly
CN113041172A (en) Skin lipid membrane bionic composition for skin barrier repair and application thereof and cosmetic
CN112754963A (en) Application method of firming anti-wrinkle skin care product
CN111920711A (en) Gel composition and preparation method and application thereof
CN108815008B (en) Composition and oil-controlling delicate cosmetic
US8357355B2 (en) Silicone elastomer exfoliating compositions
CN115778870A (en) Anti-wrinkle anti-aging composition and preparation method and application thereof
CN111135114A (en) Eye cream composition for fading fine lines and preparation method thereof
CN115040463A (en) Anti-wrinkle whitening composition
CN115670997B (en) Emulsifying system for skin, method for preparing same, and cosmetic containing same
CN114246821B (en) Moisturizing eye cream and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination